Access cutting-edge bladder cancer treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.
Access bladder cancer specialists in Phoenix at no cost
This study follows strict safety protocols and ethical guidelines
All study-related bladder cancer treatment provided free
A phase 3b, Randomized, Controlled Trial of Nadofaragene Firadenovec vs. Observation in Participants with Intermediate Risk Non-Muscle Invasive Bladder Cancer (IR NMIBC)
Sponsor: Ferring Pharmaceuticals
Check if you qualify for this bladder cancer clinical trial in Phoenix, AZ
If you're searching for bladder cancer treatment options in Phoenix, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced bladder cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.